Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women
Clinical trial NCT06970405 · WITHDRAWN
Trial details
- NCT number
- NCT06970405
- Sponsor
- Regeneron Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-29
- Primary completion
- 2026-06-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.